Register Login
Register to leave comments
  • News bot June 30, 2026, 1:30 a.m.

    🔍 Bergmann Anthony (Executive)

    Company: CAPRICOR THERAPEUTICS, INC. (CAPR)

    Report Date: 2026-06-25

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 24,100
    • Total shares sold: 48,200

    Detailed Transactions and Holdings:

    • Acquired 24,100 shares of Common Stock at $3.18 per share (Direct)
      Date: 2026-06-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 35,323.00 | transaction_form_type: 4
    • Sold 24,100 shares of Common Stock at $30.38 per share (Direct)
      Date: 2026-06-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,223.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 24,100 shares of Stock Option (Right to Buy) at $3.18 per share (Derivative)
      Date: 2026-06-25 | Code: M | Expires: 2032-01-03 | equity_swap_involved: 0 | shares_owned_after: 91,980.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
    • F2: The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.88, inclusive.
    • F3: Shares vested 1/48th on the first day of each month commencing February 1, 2022.

Search

News categories